Iterum Therapeutics (ITRM) Institutional Ownership $1.00 -0.04 (-4.22%) As of 06/12/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Iterum Therapeutics (NASDAQ:ITRM)CurrentInstitutional OwnershipPercentage9.21%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$1.13MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$229.43K Get ITRM Insider Trade Alerts Want to know when executives and insiders are buying or selling Iterum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ITRM Institutional Buying and Selling by Quarter Iterum Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/29/2025 OneDigital Investment Advisors LLC101,000$124K0.0%N/A0.292% 2/18/2025 Alpine Global Management LLC15,000$27K0.0%-76.9%0.055% 2/17/2025 Two Sigma Investments LP25,245$45K0.0%N/A0.092% 2/17/2025 Citadel Advisors LLC21,207$38K0.0%N/A0.077% 2/14/2025 Alpine Global Management LLC15,000$27K0.0%-76.9%0.055% 2/13/2025 Renaissance Technologies LLC438,816$777K0.0%N/A1.595% 1/31/2025Sanctuary Advisors LLC20,000$35K0.0%N/A0.073% 1/30/2025 Lee Financial Co16,000$28K0.0%N/A0.058% 1/28/2025 Apollon Financial LLC250,250$443K0.1%+11.3%0.909% 11/15/2024 XTX Topco Ltd33,040$36K0.0%N/A0.146% Get the Latest News and Ratings for ITRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/9/2024 Renaissance Technologies LLC64,022$73K0.0%-42.0%0.387% 8/4/2023 Apollon Wealth Management LLC200,000$214K0.0%N/A1.542% 11/10/2022 New Leaf Venture Partners L.L.C.97,084$157K0.1%-93.3%0.794% 10/6/2022 Krilogy Financial LLC20,000$32K0.0%-90.0%0.163% 7/14/2022 Krilogy Financial LLC200,000$40K0.0%N/A0.109% 11/16/2021 Squarepoint Ops LLC52,503$29K0.0%+106.9%0.029% 11/15/2021 Franklin Resources Inc.384,200$215K0.0%N/A0.210% 11/12/2021 Renaissance Technologies LLC644,567$360K0.0%-80.4%0.353% 10/25/2021 Krilogy Financial LLC81,000$45K0.0%+161.3%0.044% 9/17/2021 Virtu Financial LLC83,658$193K0.0%-37.2%0.046% 8/17/2021 Millennium Management LLC2,560,381$5.91M0.0%+3,304.5%1.429% 8/16/2021 Squarepoint Ops LLC25,382$59K0.0%-49.4%0.014% 8/16/2021 Cubist Systematic Strategies LLC89,431$207K0.0%N/A0.050% 8/13/2021 Renaissance Technologies LLC3,289,300$7.60M0.0%N/A1.836% 8/13/2021 Sigma Planning Corp17,153$40K0.0%N/A0.010% 8/13/2021QS Investors LLC384,200$888K0.0%N/A0.214% 8/12/2021 Insight Advisors LLC PA35,000$28K0.0%-88.5%0.020% 8/11/2021 Susquehanna Fundamental Investments LLC66,230$153K0.0%N/A0.037% 8/10/2021National Asset Management Inc.32,100$75K0.0%-61.0%0.018% 8/4/2021 Grimes & Company Inc.146,278$338K0.0%+17.4%0.082% 7/15/2021 Focused Wealth Management Inc100,000$231K0.0%+33.3%0.056% 5/21/2021 Citadel Advisors LLC137,026$193K0.0%-14.5%0.076% 5/19/2021 Virtu Financial LLC133,197$188K0.0%+209.0%0.074% 5/19/2021 Squarepoint Ops LLC50,196$71K0.0%N/A0.028% 5/18/2021 Millennium Management LLC75,206$106K0.0%N/A0.042% 5/18/2021 Verition Fund Management LLC112,500$159K0.0%N/A0.063% 5/18/2021 Citadel Advisors LLC137,026$193K0.0%-14.5%0.076% 5/18/2021 Jane Street Group LLC18,041$25K0.0%N/A0.010% 5/17/2021 Royal Bank of Canada19,000$27K0.0%N/A0.011% 5/17/2021 Edmond DE Rothschild Holding S.A.100,000$141K0.0%N/A0.056% Gold is soaring. Here’s how to get paid from it (Ad)Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.Click here to discover the income ETF behind it all.5/17/2021 HRT Financial LP399,479$563K0.0%+3,875.3%0.223% 5/13/2021 Barclays PLC50,000$71K0.0%N/A0.028% 5/12/2021 Geode Capital Management LLC96,173$135K0.0%+190.4%0.054% 5/12/2021 Grimes & Company Inc.124,637$176K0.0%+73.1%0.070% 5/12/2021 FineMark National Bank & Trust300,000$423K0.0%N/A0.167% 5/12/2021 UBS Group AG52,961$75K0.0%N/A0.030% 5/4/2021 Commonwealth Equity Services LLC18,500$26K0.0%N/A0.010% (Data available from 1/1/2016 forward) ITRM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ITRM shares? During the previous two years, 10 institutional investors and hedge funds held shares of Iterum Therapeutics. The most heavily invested institutionals were Renaissance Technologies LLC ($777K), Apollon Financial LLC ($443K), Apollon Wealth Management LLC ($214K), OneDigital Investment Advisors LLC ($124K), Two Sigma Investments LP ($45K), Citadel Advisors LLC ($38K), and XTX Topco Ltd ($36K).Learn more on ITRM's institutional investors. What percentage of Iterum Therapeutics stock is owned by institutional investors? 9.21% of Iterum Therapeutics stock is owned by institutional investors. Learn more on ITRM's institutional investor holdings. Which institutional investors have been buying Iterum Therapeutics stock? Of the 9 institutional investors that purchased Iterum Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Renaissance Technologies LLC ($438.82K), Apollon Wealth Management LLC ($200K), OneDigital Investment Advisors LLC ($101K), XTX Topco Ltd ($33.04K), Apollon Financial LLC ($25.50K), Two Sigma Investments LP ($25.25K), and Citadel Advisors LLC ($21.21K). How much institutional buying is happening at Iterum Therapeutics? Institutional investors have bought a total of 880,808 shares in the last 24 months. This purchase volume represents approximately $1.34M in transactions. Which Iterum Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Iterum Therapeutics stock in the last 24 months: Alpine Global Management LLC ($99.67K), and Renaissance Technologies LLC ($46.30K). How much institutional selling is happening at Iterum Therapeutics? Institutional investors have sold a total of 145,970 shares in the last 24 months. This volume of shares sold represents approximately $229.43K in transactions. Related Companies Spero Therapeutics Major Shareholders Molecular Partners Major Shareholders Inhibikase Therapeutics Major Shareholders Fate Therapeutics Major Shareholders Editas Medicine Major Shareholders Ventyx Biosciences Major Shareholders Eupraxia Pharmaceuticals Major Shareholders Larimar Therapeutics Major Shareholders FitLife Brands Major Shareholders Alector Major Shareholders This page (NASDAQ:ITRM) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iterum Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Iterum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ITRM Stock Free ITRM Stock Alerts